A randomized, open-label study to assess the safety and

Project: Research project

Project Details

Description

A randomized, open-label study to assess the safety and tolerability of AT2101 in treatement-native adult patients with type 1 Gaucher disease
StatusFinished
Effective start/end date2/27/0712/31/09

Funding

  • Amicus Therapeutics

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.